Stifel Financial
IMCR icon

Stifel Financial’s Immunocore IMCR Stock Holding History

Stifel Financial’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,222
Closed -$338K – 3760
2026
Q1 		$338K Sell
11,222
-439
-4% -$14.2K ﹤0.01% 3102
2025
Q4 		$405K Sell
11,661
-2,325
-17% -$82.1K ﹤0.01% 2976
2025
Q3 		$508K Sell
13,986
-2,844
-17% -$96.6K ﹤0.01% 2806
2025
Q2 		$528K Sell
16,830
-60
-0.4% -$1.86K ﹤0.01% 2747
2025
Q1 		$501K Buy
16,890
+1,169
+7% +$35.1K ﹤0.01% 2685
2024
Q4 		$464K Sell
15,721
-2,530
-14% -$80K ﹤0.01% 2719
2024
Q3 		$568K Sell
18,251
-1,202
-6% -$43.7K ﹤0.01% 2602
2024
Q2 		$659K Sell
19,453
-190
-1% -$9.69K ﹤0.01% 2438
2024
Q1 		$1.28M Buy
19,643
+1,405
+8% +$96.4K ﹤0.01% 2040
2023
Q4 		$1.25M Buy
18,238
+3,776
+26% +$196K ﹤0.01% 2002
2023
Q3 		$751K Buy
14,462
+4,295
+42% +$254K ﹤0.01% 2246
2023
Q2 		$610K Buy
+10,167
New +$580K ﹤0.01% 2400

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Stifel Financial's IMCR Position: Q2 2026 in Review

Stifel Financial sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 11,222 shares — an estimated $338K sold.

Stifel Financial first reported a position in IMCR in Q2 2023 and held it in 12 quarters. The position peaked at $1.28M in Q1 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Stifel Financial reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Stifel Financial sold 11,222 Immunocore shares in Q2 2026, an estimated $338K.
  • Stifel Financial first reported a position in Immunocore in Q2 2023 and held it in 12 quarters.
  • Stifel Financial's Immunocore position peaked at $1.28M in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.